United Therapeutics | UTHR - DEBITO





DEBITO Cambiamento Data
Amarin USD 0 0 2025-03
Ardelyx USD 208.26M 653K 2026-03
Baxter International USD 9.69B 93M 2026-03
Bayer EUR 36.45B 2.93B 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Insmed USD 725.8M 1.82M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
J&J USD 54.99B 7.05B 2026-03
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Moderna USD 1.3B 7M 2026-03
Omeros USD 442.16M 199K 2023-09
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06